Skip to main content

Table 2 Participant demographics and clinical characteristics at baseline

From: Internet-based digital intervention to support the self-management of hypertension compared to usual care: results of the HALCYON randomized controlled trial

 

control

liebria

total

p

 

n = 50

n = 52

n = 102

 

Sex (% male)

52.0

42.3

47.1

.434

Age

54.1 (9.1)

54.9 (6.9)

54.5 (8.0)

.633

Systolic blood pressure

144.1 (8.5)

144.0 (7.5)

144.1 (8.0)

.957

Diastolic blood pressure

92.6 (4.8)

93.6 (4.9)

93.2 (4.9)

.298

Pulse pressure

51.5 (6.8)

50.4 (6.9)

50.9 (6.8)

.422

BMI

27.1 (4.9)

28.6 (4.7)

27.8 (4.8)

.117

Antihypertensive medication intensity level (%)

 

None

40.0

40.4

40.2

1

Monotherapy

42.0

38.5

40.2

.871

Dual combination therapy

12.0

17.3

14.7

.633

Triple combination therapy

6.0

3.8

4.9

.964

Type of antihypertensive medication a (%, multiple answers possible)

 

Renine-angiotensine-

Aldosterone system blocker

52.0

48.1

50.0

.843

Antihypertensivesb

6.0

2.0

4.0

.582

Beta blocking agents

8.0

11.5

9.8

.789

Calcium channel blockers

16.0

11.5

13.7

.714

Diuretics

2.0

4.0

2.9

1

Psychotherapy (% yes)

 

Current

10.0

6.0†

8.0

.712

Ever

16.0

12.0c

14.0

.773

  1. Note: Values represent mean (SD) unless stated otherwise. 
  2. a classified based on the Anatomical Therapeutic Chemical (ATC) Classification System. 
  3. b ATC class C02. 
  4. c based on n = 50 due to missing data